IDEXX Laboratories announced the expansion of its Faecal Dx antigen testing platform in the United Kingdom to include taeniid tapeworm, covering Taenia and Echinococcus species. The company said the test is proven to detect up to twice as many intestinal parasite infections earlier than faecal flotation alone, delivering broader parasite detection in a single test for both wellness and sick-pet care. Since launching in 2012, more than 50 million Faecal Dx antigen tests have been run worldwide, and with this addition the platform now detects seven of the most clinically relevant intestinal parasite groups, including hookworm, roundworm, whipworm, flea tapeworm, taeniid tapeworms, Cystoisospora and Giardia in select panels. Taenia and Echinococcus species are recognized by the European Scientific Counsel Companion Animal Parasites as clinically important, and ESCCAP identifies Echinococcus species as one of the three key parasite groups requiring preventive control in dogs and cats due to its zoonotic risk. Current Faecal Dx antigen testing panels and profiles for IDEXX Reference Laboratories customers in the United Kingdom now include taeniid tapeworm detection at no additional cost, and results returning positive for taeniid tapeworms will automatically initiate a complimentary follow-up Echinococcus RealPCR test.
IDEXX Laboratories IncIDEXX expands its Faecal Dx antigen testing platform in the UK to detect taeniid tapeworm, broadening its product offering.
Shanghai Henlius Biotech Inc
